Sensus Healthcare Inc (SRTS)

Sensus Healthcare, Inc. is a Boca Raton, Florida-based medical device company focused on radiation therapy equipment for healthcare providers. Its product range includes low-energy superficial radiation therapy systems used in the treatment of non-melanoma skin cancers such as basal cell and squamous cell carcinoma, as well as certain other skin conditions, including keloids. The company also sells devices with imaging and treatment-planning functions, service coverage programs, transdermal infusion equipment, and related disposable safety and shielding products. In addition, Sensus distributes laser systems for applications such as hair removal, vascular lesions, acne treatment, skin toning, rejuvenation, and pigment removal, and it provides operational healthcare services for dermatology clinics. Its customers include private dermatology practices and radiation oncologists in private and hospital settings.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-SRTS
$3.15
2.9% Upside
Fair
$5.75
87.9% Upside
Bargain
Fair
0.0%
July 30, 2026
-6.5x
1.1x
2.3x
51.032 M
32.965 M
0.8%
82.3%
5.7
9.5%
Valuation • Fair Value

Sensus Healthcare Inc (NASDAQ-SRTS) Fair Value by Valuation Model

Compare the primary fair value estimate for Sensus Healthcare Inc (NASDAQ-SRTS) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$3.15

Estimated upside of 2.9% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$1.73

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$3.90

Earnings power value estimate.

Comps Fair Value

$3.50

Comparable-company valuation reference.

Analyst Price Target

$5.75

Analysts imply upside of 87.9%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Sensus Healthcare Inc (NASDAQ-SRTS) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Sensus Healthcare Inc (NASDAQ-SRTS)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

22.532 M

Current operating scale indicator.

Revenue Forecast

23.226 M

Forward revenue estimate.

EBITDA

-11.623 M

Current operating profitability reference.

EBITDA Forecast

-10.546 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Sensus Healthcare Inc (NASDAQ-SRTS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Sensus Healthcare Inc (NASDAQ-SRTS)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

1

Weak quality score that deserves closer review.

Beneish M-Score

-3.37

No elevated caution signal from this screen.

Altman Z-Score

5.7

Relatively strong balance-sheet zone.

FCF / Net Income

9.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Sensus Healthcare Inc (NASDAQ-SRTS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Sensus Healthcare Inc (NASDAQ-SRTS)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 30, 2026

Days to Earnings

9

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Sensus Healthcare Inc (NASDAQ-SRTS), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Sensus Healthcare Inc (NASDAQ-SRTS) Stock Forecast & Technical Outlook

Review Sensus Healthcare Inc (NASDAQ-SRTS) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Sensus Healthcare Inc (NASDAQ-SRTS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Buy

The 1-hour technical read for Sensus Healthcare Inc (NASDAQ-SRTS) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Sensus Healthcare Inc (NASDAQ-SRTS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Sensus Healthcare Inc (NASDAQ-SRTS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Sensus Healthcare Inc (NASDAQ-SRTS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Sensus Healthcare Inc (NASDAQ-SRTS)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Sensus Healthcare Inc (NASDAQ-SRTS) has a Strong Buy consensus, with 2 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 2
Hold 0
Sell 0
FAQ Fast Investor Answers

Sensus Healthcare Inc (NASDAQ-SRTS) Stock FAQ

Quick answers about Sensus Healthcare Inc (NASDAQ-SRTS) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$3.15
Estimated upside 2.9%
Valuation Rating
Undervalued
Estimated upside of 2.9%
Analyst Target
$5.75
Implied upside 87.9%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Sensus Healthcare Inc (NASDAQ-SRTS) is $3.15. This implies an estimated upside of 2.9% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 2.9% versus the current market price.

The available analyst price target for Sensus Healthcare Inc (NASDAQ-SRTS) is $5.75. The analyst target implies estimated upside of 87.9%.

The current financial health read for Sensus Healthcare Inc (NASDAQ-SRTS) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Sensus Healthcare Inc (NASDAQ-SRTS) is July 30, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Sensus Healthcare Inc (NASDAQ-SRTS) is -6.5x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Sensus Healthcare Inc is 51.032 M.

The current enterprise value listed for Sensus Healthcare Inc is 32.965 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Sensus Healthcare Inc is NASDAQ-SRTS, and the stock is listed on NASDAQ.

Sensus Healthcare Inc (NASDAQ-SRTS) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Sensus Healthcare Inc is 0.8%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Sensus Healthcare Inc is 82.3%. Free float helps investors understand how much of the share base is available for public trading.